SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001662524-17-000005
Filing Date
2017-11-07
Accepted
2017-11-07 17:25:00
Documents
54
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 AKCEA THERAPEUTICS, INC. 10-Q 9-30-2017 form10q.htm 10-Q 960651
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 12053
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11877
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5744
  Complete submission text file 0001662524-17-000005.txt   5245282

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT akca-20170930.xml EX-101.INS 1063308
6 XBRL TAXONOMY EXTENSION SCHEMA akca-20170930.xsd EX-101.SCH 43331
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akca-20170930_cal.xml EX-101.CAL 54843
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akca-20170930_def.xml EX-101.DEF 224619
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE akca-20170930_lab.xml EX-101.LAB 596046
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akca-20170930_pre.xml EX-101.PRE 328615
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38137 | Film No.: 171184463
SIC: 2834 Pharmaceutical Preparations